Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
Loading
Price-to-book ratio
3Y CAGR
+24.0%/yr
vs -24.5%/yr prior
5Y CAGR
+9.6%/yr
Recent acceleration
Acceleration
+48.5pp
Accelerating
Percentile
P43
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
2 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 3.59 | +52.3% |
| 2024 | 2.36 | +33.9% |
| 2023 | 1.76 | -6.5% |
| 2022 | 1.89 | -39.7% |
| 2021 | 3.13 | +37.9% |
| 2020 | 2.27 | -12.1% |
| 2019 | 2.58 | -55.6% |
| 2018 | 5.82 | -15.4% |
| 2017 | 6.88 | +20.5% |
| 2016 | 5.71 | - |